|
DIAPH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.640200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.949200E-01 |
| Normal-vs-Stage2 |
6.411000E-01 |
| Normal-vs-Stage3 |
3.029200E-01 |
| Normal-vs-Stage4 |
5.952400E-01 |
| Stage1-vs-Stage2 |
3.980000E-01 |
| Stage1-vs-Stage3 |
1.835640E-01 |
| Stage1-vs-Stage4 |
3.670600E-01 |
| Stage2-vs-Stage3 |
8.335400E-01 |
| Stage2-vs-Stage4 |
8.573800E-01 |
| Stage3-vs-Stage4 |
9.587400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.373000E-01 |
| Normal-vs-AfricanAmerican |
6.418200E-01 |
| Normal-vs-Asian |
3.071800E-01 |
| Caucasian-vs-AfricanAmerican |
5.978400E-01 |
| Caucasian-vs-Asian |
6.394800E-01 |
| AfricanAmerican-vs-Asian |
7.960400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.840140E-02 |
| Normal-vs-Female |
2.204400E-04 |
| Male-vs-Female |
6.82869999990565E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.860600E-01 |
| Normal-vs-Extreme_Weight |
3.260800E-01 |
| Normal-vs-Obese |
1.668780E-01 |
| Normal-vs-Extreme_Obese |
9.281700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.549600E-01 |
| Normal_Weight-vs-Obese |
2.107400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.348800E-01 |
| Extreme_Weight-vs-Obese |
5.118400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.759600E-01 |
| Obese-vs-Extreme_Obese |
1.992390E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.434100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.104000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.227160E-01 |
| Normal-vs-Age(81-100Yrs) |
4.139200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.157830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.237500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.824400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.688000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.319800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.716600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.363560E-01 |
| Normal-VS-Type2 PRCC |
6.385600E-01 |
| Normal-VS-KIRP CIMP |
1.516850E-03 |
| Normal-VS-Unclassified PRCC |
3.864600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.542000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.761700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.249990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.076440E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.507400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.00600000000484E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.344600E-01 |
| Normal-vs-N1 |
9.761600E-02 |
| Normal-vs-N2 |
2.034800E-01 |
| N0-vs-N1 |
4.640200E-02 |
| N0-vs-N2 |
1.742440E-01 |
| N1-vs-N2 |
2.561600E-01 |
|
|
